Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.490
-0.010 (-0.40%)
At close: Oct 8, 2025, 4:00 PM EDT
2.590
+0.100 (4.02%)
After-hours: Oct 8, 2025, 7:59 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $17.59 million as of October 8, 2025. Its market cap has increased by 144.51% in one year.
Market Cap
17.59M
Enterprise Value
4.51M
1-Year Change
144.51%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $17.59M, a decrease of -95.70%. That is a compound annual growth rate of -22.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 17.66M | -45.27% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | 86.15M | 123.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.66B |
| Johnson & Johnson | 455.61B |
| AbbVie | 409.45B |
| UnitedHealth Group | 332.47B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 230.80B |